When it comes to the prevention and management of type 2 diabetes, a combination of regular exercise, maintaining a healthy body weight, and following evidenced-based dietary recommendations remains sound guidance for the general population. However, in combination with recent technological advances, the emerging field of precision nutrition offers a novel approach to tailor prevention and treatment of this chronic disease to individual characteristics — such as genetic background or gut microbiome. So just how close are we to applying precision nutrition effectively in our clinical and public health settings, to tackle a disease affecting nearly 425 million adults worldwide?
Precision nutrition, or personalized nutrition is a method of tailoring nutrition recommendations based on a person’s DNA, unique microbiome, health history, various environmental exposures such as diet or lifestyle habits, and an emerging area of research called metabolomics. (Metabolomics studies metabolites, or small molecules that are created from reactions in cells, such as the digestion of food. All of the metabolites in a person’s body produce their “metabolome,” which can potentially reveal dietary patterns.)
In the February 2018 issue of The Lancet Diabetes & Endocrinology, Drs. Dong Wang and Frank Hu from the department of nutrition at Harvard T.H. Chan School of Public Health reviewed recent advances and challenges in the applications of precision nutrition to diabetes prevention and management.
“It is well-known that the response to the same dietary intervention varies considerably across individuals,” said Dr. Wang, a research fellow in the department and lead author of the paper. “Thus, the concept of personalized or precision nutrition in disease prevention and management has attracted a great deal of attention in the scientific community and the general public. However, it is important to assess current evidence before widespread applications in clinical and public health settings.”
Several areas of research in the application of precision nutrition in diabetes prevention and management were reviewed by the authors, including:
As ideal as this technology seems for improving patient care and health outcomes, it is teamed with obstacles that prevent it from being easily embraced in clinical, public health, or research settings. These include the high cost of collecting and analyzing omics information, challenges in interpreting the big data, and a lack of well-designed clinical intervention studies. Research is also needed to see if precision nutrition interventions are more effective than the standard approach of providing general diabetes nutrition education focused on behavioral change.
The study authors also note that although genetic and microbiota data add some value, an individual’s food choices are strongly influenced by environmental factors such as level of income and education, social support systems, and lifestyle habits (sleep, amount of screen time). These influences may play a larger role than genetic and biochemical measures in determining what a person will eat, and therefore remain key considerations when developing a program to prevent and manage diabetes.
“Despite recent advances in technologies and some promising data from precision nutrition studies, this area of research remains at an early stage,” said Dr. Hu, professor and chair of the department of nutrition, and senior author of the paper. “We should manage unrealistically high expectations or overpromise of precision nutrition. To address major public health problems like diabetes, we need to combine public health strategies with precision nutrition technologies.”